Showing results (191-200 of 351) with videos related to

Sort By:
Pageof 36
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 19, 2003
Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blockerMarie-Luise Gross, Eberhard Ritz, Arne Schoof, et al.
Expert Opinion on Pharmacotherapy|March 5, 2013
Cinacalcet hydrochloride for the treatment of hyperparathyroidismNicolas Verheyen, Stefan Pilz, Kathrin Eller, et al.
Research in Nursing & Health|April 22, 2020
Is there an association between social determinants and care dependency risk? A multi-state model analysis of a longitudinal studyAlice Schneider, Stefan Blüher, Ulrike Grittner, et al.
Kidney Medicine|May 11, 2023
Estimated GFR Accuracy When Cystatin C- and Creatinine-Based Estimates Are Discrepant in Older AdultsO Alison Potok, Dena E Rifkin, Joachim H Ix, et al.
European Heart Journal|May 25, 2011
Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failureAndreas Tomaschitz, Stefan Pilz, Eberhard Ritz, et al.
Kidney International|April 23, 2002
ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cellsOliver Vonend, Vitus Oberhauser, Ivar von Kügelgen, et al.
Clinical and Experimental Nephrology|July 26, 2017
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120Gerald Schulman, Tomas Berl, Gerald J Beck, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysisVera Krane, Detlef H Krieter, Manfred Olschewski, et al.
Nephron. Experimental Nephrology|March 10, 2007
The combination of ACE inhibition plus sympathetic denervation is superior to ACE inhibitor monotherapy in the rat renal ablation modelPeter Hamar, Gabor Kokeny, Peter Liptak, et al.
BMC Nephrology|October 8, 2016
The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trialsGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Pageof 36